A meta-analysis of 18 studies with a total of 8408 patients with cancer demonstrated that factor V Leiden was associated with a more than twofold increased risk of VTE [odds ratio (OR): 2.28, 95% confidence interval (CI): 1.51–3.48] (Table 1) [17▪]. This evidence concerns the gene F5 and cancer.